Colinz Laboratories Quarterly Results for Trading Insights

COLINZ • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Quarterly Results

Colinz Laboratories Quarterly Results Key Highlights

  • Revenue of ₹7 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 8.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹1.97 in March 2025 (+0.0% vs March 2025)

Colinz Laboratories Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 6 7 7 7 7 -14.3% -
Net Profit (₹ Cr) 1 1 1 1 0 - -
EBITDA (₹ Cr) 1 1 1 1 1 - -
EPS (₹) 1.80 1.97 1.93 1.82 0.74 - -
Operating Margin (%) 7.0% 8.0% 8.0% 9.0% 8.0% - -

Colinz Laboratories Share Price Trend Around Quarterly Results

Visualize Colinz Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Colinz Laboratories share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 14.3%
EBITDA Margin 14.3%
Operating Margin 8.0%
ROE (Annual) 10.0%

Balance Sheet Highlights

Total Assets ₹12 Cr
Total Equity ₹10 Cr
Current Assets ₹9 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹-2 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹-2 Cr

Current Market Data

Current Price ₹65.18
Exchange BSE
Last Updated Feb 05, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Colinz Laboratories quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹391,547.47 Cr 1702.6 14,875 3,125 +10.8% - 21.0% 131.0
Divis Laboratories
Sept 2025
₹160,887.23 Cr 6141.5 2,860 689 +7.1% - 24.1% 236.5
Torrent Pharmaceuti…
Sept 2025
₹136,071.99 Cr 3976.4 3,219 591 +11.3% - 18.4% 226.7
Cipla
Sept 2025
₹110,697.00 Cr 1333.3 7,716 1,353 +12.0% - 17.5% 79.7
Dr Reddys Laborator…
Sept 2025
₹103,126.93 Cr 1244.9 9,135 1,337 +1.1% - 14.6% 76.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores